InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by KANGO SUJAY, Directeur Exécutif. Officer active across 1 companies, notably Acceleron Pharma INC. In total, 8 reports have been published. The latest transaction was filed on 27 September 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
18,509 shares
Common Stock
SEC:0001104659-21-142269·
18,509 shares
Common Stock
SEC:0001104659-21-142269:0·
€173,5955,000 shares@ €34.718939.2% of flow
Common Stock
SEC:0001179110-21-008949·
€173,5955,000 shares@ €34.718919.6% of flow
Common Stock
SEC:0001179110-21-008949:0·
€173,2085,000 shares@ €34.641639.1% of flow
Common Stock
SEC:0001179110-21-008894·
€173,2085,000 shares@ €34.641619.6% of flow
Common Stock
SEC:0001179110-21-008894:0·
€95,686887 shares@ €107.876121.6% of flow
Common Stock
SEC:0001179110-21-006494·
€95,686887 shares@ €107.876110.8% of flow
Common Stock
SEC:0001179110-21-006494:0·
8 of 8 declarations
About KANGO SUJAY
Sujay Kango is the Executive Vice President and Chief Commercial Officer at Acceleron Pharma Inc. He is responsible for commercial strategy and operations management. His expertise in the pharmaceutical sector helps guide growth and innovation initiatives.
